Domingo Francisco Javier
Díez Martínez
Investigador hasta 2021
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (39)
2024
-
Circulating biomarkers of myocardial remodelling: current developments and clinical applications
Heart, Vol. 110, Núm. 19, pp. 1157-1163
-
Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations
Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565
-
Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management
Hypertension, Vol. 81, Núm. 2, pp. 218-228
2023
-
Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Journal of Sport and Health Science, Vol. 12, Núm. 2, pp. 147-157
-
Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides
JACC: Heart Failure, Vol. 11, Núm. 1, pp. 58-72
-
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694
-
Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines
Metabolism: Clinical and Experimental, Vol. 138
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
-
Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study
Journal of Cardiovascular Magnetic Resonance, Vol. 24, Núm. 1
-
Heart failure in chronic kidney disease: The emerging role of myocardial fibrosis
Nephrology Dialysis Transplantation, Vol. 37, Núm. 5, pp. 817-824
2021
-
Heart failure-related skeletal myopathy. Potential involvement of myokines
Revista espanola de cardiologia (English ed.), Vol. 74, Núm. 12, pp. 1008-1012
-
Identification of sex-specific biomarkers predicting new-onset heart failure
ESC Heart Failure, Vol. 8, Núm. 5, pp. 3512-3520
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
2020
-
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)
Scientific Reports
-
Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?
Journal of Clinical Medicine, Vol. 9, Núm. 2
-
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study
Diabetologia, Vol. 63, Núm. 5, pp. 1043-1054
2019
-
Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study
Journal of Cardiovascular Electrophysiology, Vol. 30, Núm. 8, pp. 1231-1240
-
Circulating biomarkers predicting longitudinal changes in left ventricular structure and function in a general population
Journal of the American Heart Association, Vol. 8, Núm. 2
-
Circulating long noncoding RNA LIPCAR Predicts heart failure outcomes in patients without chronic kidney disease
Hypertension, Vol. 73, Núm. 4, pp. 820-828
-
Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?
American Journal of Hypertension